MicroRNA modulated networks of adaptive and innate immune response in pancreatic ductal adenocarcinoma

Despite progress in treatment strategies, only ~24% of pancreatic ductal adenocarcinoma (PDAC) patients survive >1 year. Our goal was to elucidate deregulated pathways modulated by microRNAs (miRNAs) in PDAC and Vater ampulla (AMP) cancers. Global miRNA expression was identified in 19 PDAC, 6 AMP...

Descripción completa

Detalles Bibliográficos
Autores principales: Felix, Tainara F., Lopez Lapa, Rainer M., de Carvalho, Márcio, Bertoni, Natália, Tokar, Tomas, Oliveira, Rogério A., M. Rodrigues, Maria A., Hasimoto, Cláudia N., Oliveira, Walmar K., Pelafsky, Leonardo, Spadella, César T., Llanos, Juan C., F. Silva, Giovanni, Lam, Wan L., Rogatto, Silvia Regina, Amorim, Luciana Schultz, Drigo, Sandra A., Carvalho, Robson F., Reis, Patricia P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544344/
https://www.ncbi.nlm.nih.gov/pubmed/31150430
http://dx.doi.org/10.1371/journal.pone.0217421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544344/
https://www.ncbi.nlm.nih.gov/pubmed/31150430
http://dx.doi.org/10.1371/journal.pone.0217421

Ejemplares similares